Where a BCL-2 Inhibitor Fits in for CLL, Early Results

patientpower has 2382 videos Subscribe Here

Description: Dr. John Seymour is a leading Australian CLL specialist who has been studying ABT-199, a BCL2 inhibitor, to see if it has promise, and the early results are positive. In this interview he explains where this oral medicine might fit in in combination with other new medicines to help revolutionize CLL care.

Get email alerts | http://www.patientpower.inf...

Subscribe on YouTube |
Like on Facebook |
Follow on Twitter |
Shared By : patientpower
Posted on : 10/30/13
Added : 4 years ago
Category : Other